SCHEDULE II VALUATION AND QUALIFYING ACCOUNTS

12 Months Ended

Dec. 31, 2017

Schedule Of Valuation And Qualifying Accounts [Abstract]

Schedule of Valuation and Qualifying Accounts

TEVA PHARMACEUTICAL INDUSTRIES LIMITED
SCHEDULE II—VALUATION AND QUALIFYING ACCOUNTS
Three Years Ended December 31, 2017
(U.S. $ in millions)
Column A		Column B		Column C				Column D		Column E
		Balance at beginning of period		Charged to costs and expenses		Charged to other accounts		Deductions		Balance at end of period
Allowance for doubtful accounts:
	Year ended December 31, 2017	$	191	$	12	$	51	$	(22)	$	232
	Year ended December 31, 2016	$	146	$	5	$	61	$	(21)	$	191
	Year ended December 31, 2015	$	149	$	18	$	(6)	$	(15)	$	146

Allowance in respect of carryforward tax losses:
	Year ended December 31, 2017	$	1,690	$	173	$	390	$	(748)	$	1,505
	Year ended December 31, 2016	$	760	$	135	$	1,137	$	-342	$	1,690
	Year ended December 31, 2015	$	671	$	249	$	1	$	-161	$	760